Skip to main content
. 2022 Nov 19;19:277. doi: 10.1186/s12974-022-02635-3

Table 1.

Comparison of the clinical parameters and splenic T cell populations in EAE mice following individualized treatment with fingolimod or vehicle

Vehicle FTY720 p value
Clinical parameters
 Maximum score 3 (2.25–3) 2.38 (1.18–2.75)  < 0.05
 dpi peak 15 (14–17) 15 (14–15.25) ns
 Severity index 0.75 (0.50–1.00) 0.625 (0.33–0.75) ns
 Peak accumulated score 6.50 (5.63–9.00) 5.69 (3.68–6.81) ns
 Total accumulated score 37.25 (23.00–42.38) 18.88 (12.59–27.16)  < 0.01
 % Recovery 25.00 (12.50–33.30) 72.73 (53.41–80.24)  < 0.01
 Recovery index 0.093 (0.04–0.17) 0.16 (0.10–0.21)  < 0.05
 Residual score 2.25 (1.00–2.63) 0.50 (0.50–0.88)  < 0.01
Spleen
 % CD3+/Total blood cells 15.15 ± 0.97 11.06 ± 0.93  < 0.01
 % CD4+/Total blood cells 9.11 ± 0.64 7.75 ± 0.63 ns
 % CD8+/Total blood cells 4.98 ± 0.36 2.79 ± 0.28  < 0.001
 % CD3+CD25+/Total blood cells 1.32 ± 0.08 1.09 ± 0.07  < 0.05
 % CD3+CD69+/Total blood cells 1.77 ± 0.12 1.86 ± 0.10 ns

The data are expressed as the median (IQR) for the clinical parameters and the mean ± SEM for the splenic parameters. The results of applying a Student’s t-test or a non-parametric Mann–Whitney test are shown: dpi day post-immunization; IQR interquartile range; ns non-significant